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TranscriptionThe transcription factor Elf5 plays an important role in mammary gland development. However, because of
the embryonic lethality of Elf5 straight knockout mice, prior studies have been limited to experiments with
Elf5 haploinsufﬁcient animals, overexpression systems or transplants. Here, we have utilized K14-Cre to
generate mammary-gland speciﬁc Elf5 conditional knockout mice. During pregnancy, Elf5-null mammary
epithelium completely failed to initiate alveologenesis, and a characteristic of virgin ductal epithelial cells
persisted postpartum. We demonstrate that the loss of Elf5 leads to the absence of alveolar secretory markers
conﬁrming previous published data. Interestingly, the developmental block due to a lack of Elf5 could not be
restored by multiple gestations. Elf5-null mammary epithelial cells also display disorganized cell structures
as evident by altered cell polarities, which might be the cause for collapsed lumina. We observe reduced
levels of Stat5 and attenuated Stat5 activity as measured by p-Stat5 levels both in Elf5-null mammary glands
as well as cultured mammary epithelial cells. This data suggests that the failure of alveolar and lactogenic
differentiation due to the loss of Elf5 is mediated in part due to impaired Stat5 activity. In support of this
hypothesis, we show by ChIP experiments that Stat5a promoter contains a conserved Elf5-binding site that is
occupied by Elf5 in mammary glands. Mammary epithelia lacking Elf5 exhibited downregulation of several
other critical genes involved in alveologenesis, suggesting Elf5 as a master regulator in alveolar development.
We propose a model for Elf5-mediated alveolar development, in which Elf5 regulates the expression of key
mediators of the PrlR/Jak2/Stat5 signaling pathway.© 2009 Elsevier Inc. All rights reserved.Introduction
The generation of themature and functional lobuloalveolar units of
the mammary gland is a well-coordinated developmental program
(Oakes et al., 2006). This process is governed by endocrine signals
generated predominantly by prolactin and steroid hormones such as
progesterone and a network of critical transcription factors that
activates target genes involved in cell fate determination, proliferation
and differentiation (Brisken and Rajaram, 2006). One such transcrip-; Elf5, E74-like factor 5; ERα,
pithelium speciﬁc Ets; Ets, E
bitor of kappa B kinase alpha;
18; Lmo4, LIM domain only 4;
NKCC1, Na–K–Cl cotransporter
hoglycerate kinase-neomycin;
SOCS, suppressor of cytokine
ription 5; p-Stat5, phosphory-
rotein.
l rights reserved.tion factor is E74-like factor 5 (Elf5, also known as ESE-2), amember of
the EpitheliumSpeciﬁc Ets (ESE) subfamily belonging to Ets (E twenty-
six)-domain transcription factor family (Sharrocks, 2001). All Ets
family proteins contain a conserved DNA binding domain called Ets-
domain that binds to regulatory regions of target genes (Sharrocks,
2001). As transcription factors, Ets proteins regulate a spectrum of
normal biological processes including development, differentiation,
homeostasis, proliferation and apoptosis (Sharrocks et al., 1997). Not
surprisingly, many of the Ets family members not only contribute to
normal cellular development, but have oncogenic and tumor suppres-
sive activity and their mis-regulation is associated with many of the
processes that lead to cancer initiation, progression and metastasis
(Desmaze et al., 1997; Dittmer and Nordheim, 1998; Peter et al., 1997).
Indeed, recent studies have shown that the loss of Elf5 is frequently
associatedwith humanmammary carcinoma cells and in breast cancer
tissues suggesting a potential role of this transcription factor to act as a
tumor suppressor in breast cancer (Ma et al., 2003; Zhou et al., 1998).
Elf5 has been shown to be restricted to tissues rich in glandular or
secretory epithelial cells such as mammary gland, salivary gland,
kidney, lung and stomach (Lapinskas et al., 2004; Metzger et al.,
2007). Expression of Elf5 has also been discovered in the inner root
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(Choi et al., 2008; Tummala and Sinha, 2006). In addition, Elf5 is
highly restricted to the extraembryonic ectoderm, which is essential
for mammalian placental formation and the survival of the embryo in
utero (Donnison et al., 2005). Indeed, the generation of Elf5 knockout
mice has demonstrated that embryos lacking both alleles of Elf5 die
very early during embryogenesis and exhibit speciﬁc defects in the
formation of extraembryonic ectoderm (Donnison et al., 2005; Zhou
et al., 2005). Signiﬁcantly, Elf5 is highly induced during pregnancy and
is primarily restricted to the luminal epithelial cells of mammary
gland, and coincidently, heterozygous Elf5 females display impaired
mammary alveolar morphogenesis in speciﬁc strains of mice (Zhou et
al., 2005). Furthermore ectopic expression of Elf5 can rescue the
alveolar dysmorphogenesis phenotype of mammary epithelial cells
lacking prolactin receptor (PrlR) (Harris et al., 2006).
These data support the notion that Elf5 is one of the important
factors that regulate developmental events of mammary alveolar
epithelial cells and its regulation involves the prolactin signaling
pathway. However, the underlying molecular and cellular events
controlled by Elf5 are not fully understood due to the early embryonic
lethality of mice lacking both Elf5 alleles. Therefore, in vivo studies of
Elf5 in mammary epithelial development have been performed in Elf5
heterozygous mice or with transplants from Elf5 null animals (Oakes
et al., 2008; Zhou et al., 2005). Although these studies have clearly
established that Elf5 is essential for lobuloalveologenesis, the
limitations of the aforementioned systems warrant further investiga-
tions with mouse models that allow studies involving the complete
loss of Elf5 in a more physiological context.
In this study, we established an Elf5 tissue-speciﬁc knockout
mouse line to circumvent the embryonic lethality associated with
mutation of the Elf5 gene during embryogenesis and to examine the
effect of the complete loss of Elf5 in different stages of development.
To elucidate the precise roles of Elf5 in mammary epithelial
development, we have utilized the Cre–loxP system leading to
mammary epithelium-speciﬁc deletion of Elf5. We successfully
generated mice (K14-Cre/Elf5f/f) carrying two Elf5 ﬂoxed alleles and
a Cre transgene under control of the human cytokeratin 14 (K14) gene
promoter, which is active in dividing cells of several stratiﬁed
epithelial tissues, including skin and mammary gland. Our data
show that K14-Cre/Elf5f/f dams lack Elf5 in mammary gland tissue,
and completely fail to initiate lobuloalveologenesis and maintain
virgin-like ductal features with an underdeveloped morphology even
at parturition. We show that the morphological alterations in Elf5 null
mammary gland are associatedwith alterations of critical components
of the PrlR/Jak2/Stat5 signaling pathway as well as other known
mediators of the mammary gland developmental program. Taken
together, our K14-Cre-mediated knockout of Elf5 unequivocally
demonstrates that this transcription factor is critical for the mammary
gland development during alveologenesis. The development of Elf5-
null mouse model will facilitate a better understanding of the
molecular mechanisms that underlie the alveolar switch.
Materials and methods
Generation of conditional Elf5 knockout mice
The mouse Elf5 genomic DNAwas isolated by a PCR screening from
a bacterial artiﬁcial chromosome clone of a 129 strain mouse
embryonic stem (ES) cell genomic library. The vector backbone for
the targeting construct was PGKneoF2L2DTA, containing a PGK-neo
cassette ﬂanked by loxP and FRT sites (the plasmid was provided
kindly by Dr. P. Soriano, Fred Hutchinson Cancer Research Center,
Seattle). To select against ES cells that have incorporated the targeted
DNA by non-homologous recombination, PGK-dta encoding the
diphtheria toxin gene was used as a negative selectable marker. The
Elf5 targeting vector was designed to contain two homologous armsfor efﬁcient homologous recombination (Fig. S1A). For 3′ homologous
arm, a 3 kb fragment with exon 7 was ampliﬁed by PfuUltra
polymerase (Stratagene), introducing a NheI site on the 5′-end and
a HindIII site on the 3′-end of the ampliﬁcation product. The PCR
product was cloned into the NheI–HindIII sites of the PGKneoF2L2DTA
vector. A 5.3 kb fragment having exons 4 and 5 was also ampliﬁed to
introduce a SacII site at the 5′-end and a NotI site at the 3′-end. The
5.3 kb 5′ homologous armwas then cloned into the SacII–NotI sites of
the PGKneoF2L2DTA vector carrying a 3 kb of the 3′ homologous arm.
The ﬂoxed regionwas ampliﬁed from a 1.2 kb XmaI fragment with the
exon 6 containing most of Ets domain, and then introduced into XmaI
site of the PGKneoF2L2DTA vector harboring two homologous arms.
This cloning into XmaI site allowed the insertion of the ﬂoxed region
between the ﬁrst loxP site and the ﬁrst FRT site. The ﬁnal targeting
vector was linearized using SacII, phenol–chloroform puriﬁed, and
electroporated into ES cells. The selection and expansion of ES cell
clones were performed by Gene Targeting and Transgenic Core at
Roswell Park Cancer Institute.
Two correctly targeted clones were used to generate chimeras and
mice judged to be highly chimeric on the basis of agouti coat color
were crossed with C57BL/6 mice. After getting germ-line chimeras,
the offspring were identiﬁed by Southern blot analysis. The Southern
blot analysis using XhoI–SalI genomic digestion and 5′ probe
exhibited two distinct bands of 11.7 kb (ﬂoxed allele) and 9.7 kb in
size (wild-type allele). The HpaI Southern blot with 3′ probe yielded
bands of 8.8 kb (ﬂoxed allele) and 6.8 kb in size (wild-type allele).
Thereafter mice were intercrossed to obtain progenies and crossed
with K14- or MMTV-Cre (D-line) transgenic mouse lines (The Jackson
Laboratory) to generate Cre-mediated knockout mice of Elf5.
Genotyping of progenies was performed by PCR analysis of tail DNA
using four primers (Fig. 1A). For the wild-type allele, a 661 bp product
was obtained from the combination of primer A (5′-TTCCGAGTGGT-
TAGGTCAGAAGCC-3′) and primer D (5′-GAGTTTCTCTTCCTGC-
CACCCGTG-3′). The primer B (5′-GACAATAGCAGGCATGCTGGGGAT-
3′) was located within the PGK-neo cassette and generated a 424 bp
product only on the ﬂoxed allele with primer D. The primer set C (5′-
CCTCTCACAGTGACTGCAGTTAAGTTCCG-3′) and D was utilized to
genotype the knockout allele (765 bp). All experimental procedures
involving mice were approved by the Institutional Animal Care and
Use Committee of the State University of New York at Buffalo.
Whole-mount analysis and histological analysis
For whole-mount staining, fourth mammary glands were excised
and spread on microscope slides. The tissues were ﬁxed in Carnoy's
ﬁxative [6 parts 100% ethanol, 3 parts chloroform, 1 part glacial acetic
acid], washed in 70% ethanol, hydrated by passing through decreasing
ethanol concentration and stained in carmine alum stain [0.2%
carmine, 0.5% aluminum potassium sulfate] overnight at room
temperature. After staining, the slides were dehydrated through
increasing ethanol concentrations, cleared in xylene and mounted
with Permount (Fisher Scientiﬁc).
For histological analysis, mammary gland specimens were ﬁxed
overnight in neutral buffered formalin [3.7% formaldehyde buffered to
pH 6.8–7.2 with monobasic and dibasic sodium phosphate], dehy-
drated and embedded in parafﬁn. Tissue blocks were sectioned into
5 μm and stained with hematoxylin and eosin.
Primary mammary epithelial cell culture and viral infection
Isolation and adenoviral infection of primary mammary epithelial
cells were performed as described previously (Naylor et al., 2005).
Brieﬂy, primary mammary epithelial cells were infected with either
Ad-Cre or Ad-GFP (Vector Biolabs) in suspension for 45 min before
being plated at equal density on BM (Basement Membrane) matrix
(Matrigel, BD Biosciences). Cells were cultured in DMEM/F12medium
Fig. 1. Generation of Elf5 conditional knockout mice. (A) Schematic representations of the wild-type (+) Elf5 allele, the ﬂoxed (f) allele and the predicted Elf5 knockout allele after
Cre-mediated deletion. Red box indicates exon 6 encoding for most of the Ets domain of the Elf5 gene; gray and white boxes indicate exons of the Elf5 gene and a PGK-neo cassette,
respectively; orange triangles ﬂanking both the exon 6 and the FRT-ﬂanked PGK-neo cassette display loxP sites. The positions of the primers used for genotype are denoted by small
arrows. (B) Mammary epithelial X-gal staining. To determine the efﬁciency of excision of K14-Cre transgene, whole-mount X-gal staining on a 5 week ROSA K14-Cre mammary gland
revealed staining in both ductal network and terminal end buds (a). In cross-section, the extent of staining in the ROSA K14-Cre mice is seen to affect the majority of the luminal
epithelial cells and myoepithelial cells (b). (c) Higher magniﬁcation of the mammary epithelium shows Cre activity in both mammary luminal and myoepithelial cells. (C) PCR
analysis on genomic DNA of tail biopsies for genotyping of K14-Cre/Elf5+/+, K14-Cre/Elf5+/f and K14-Cre/Elf5f/f animals. The K14 promoter is active in skin, accounting for the
presence of the knockout allele in the tail clip. Primers A, B, C and Dwere used to amplify genomic DNA.Whilewild-typemice show a single band of 661 bp PCR product, the K14-Cre/
Elf5+/f mice display all bands of 661 bpwild-type allele (primers A/D), 424 bp ﬂoxed allele (primers B/D) and 765 bp knockout allele (primers C/D). Elf5 null mutant mice (K14-Cre/
Elf5f/f) are identiﬁed by the absence of wild-type allele and the presence of both the ﬂoxed and the knockout alleles. (D) Western blot analysis to verify the deletion of Elf5 protein
expression in mammary glands of Elf5 mutants. Proteinwas extracted from 1-day lactating mammary gland of wild-type, heterozygous and homozygous Elf5 mutant mice with K14-
Cre-mediated recombination. The lysates were subjected toWestern blot analysis using anti-Elf5 or anti-β-tubulin antibodies, as indicated. No Elf5 protein expressionwas detected in
K14-Cre/Elf5f/f mammary gland. β-Tubulin protein blot serves as a loading control. Bar, Ba, 0.5 mm, Bb, 100 μm, Bc, 40 μm.
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ml), FBS (10%), penicillin/streptomycin (100 U/ml and 100 μg/ml
respectively), Gentamycin (50 μg/ml). For inducing differentiation,
3 μg/ml of prolactin was added.
Immunohistochemistry and immunoﬂuorescence
Mammary glands were ﬁxed in neutral buffered formalin over-
night and embedded in parafﬁn. 5 μm sections were baked for 30 min
at 60 °C, and then deparafﬁnized. For immunohistochemistry, heat-
induced antigen retrieval was performed by microwaving sections in10 mM sodium citrate, pH 6.0 for 20 min. Endogenous peroxidase
activity was quenched by incubating the sections in 3% hydrogen
peroxide solution for 10 min. All incubations were performed at room
temperature unless otherwise stated. Endogenous biotin was blocked
using the Streptavidin/Biotin blocking kit according to the manufac-
turer's instructions (Vector Laboratories). After blocking in 5% BSA/
0.05% Tween-20, primary antibodies were applied (Elf5, 1:100, Santa
Cruz Biotechnology; p-Stat5, 1:200, Cell Signaling Technology; Wap,
1:300, Santa Cruz Biotechnology; PR, 1:50, Abcam; Ki67, 1:50,
Novocastra; ERα, 1:500, Santa Cruz Biotechnology; Laminin, 1:50,
Sigma) and the sections were incubated overnight at 4 °C.
Table 1
Primer sequences used in RT-PCR analysis.
Gene Primer Product size (bp)
β-Actin Sense: ACCAACTGGGACGATATGGAGAAGA 214
Antisense: TACGACCAGAGGCATACAGGGACAA
β-Casein Sense: GGTGAATCTCATGGGACAGC 160
Antisense: CACAGGGGGTTGAGCAATAG
α-Casein Sense: CAGCATAGCAGCAGTGAGGA 172
Antisense: CTTCCTGAGCACTTGCCATT
Gapdh Sense: CATGGCCTTCCGTGTTCCTA ∼200
Antisense: CCTGCTTCACCACCTTCTTGAT
Cldn7 Sense: AGCATGTTCCTGGATTGGTC 128
Antisense: CCAGAAGGACCAGAGCAGAC
Elf5 Sense: GTGGCATCAAGAGTCAAGACTGTC 220
Antisense: CTCAGCTTCTCGTACGTCATCCTG
HPRT Sense: GCTGGTGAAAAGGACCTCT 246
Antisense: CACAGGACTAGAACACCTGC
Id2 Sense: CTATCGTCAGCCTGCATCAC 111
Antisense: GGAATTCAGATGCCTGCA A
IKKα Sense: CGTTAGCACAAATGATAGAAGA 125
Antisense: TCATTCTGCTAACCAACTCCAA
K18 Sense: AAGGTCTGGAAGCCCAGATT 191
Antisense: CTTGGTGGTGACAACTGTGG
Lmo4 Sense: CCCAAGGCAACGTGTATCAT 126
Antisense: GGGCTGTGGGTCTATCATGT
Muc-1 Sense: TTCCAACCCAGGACACCTAC 119
Antisense: ATTACCTGCCGAAACCTCCT
NKCC1 Sense: GGTTCTCCAAACTCACGG 600
Antisense: GTCTTGCCATCCTCTTCCTC
SOCS3 Sense: GAGATTTCGCTTCGGGACTA 200
Antisense: ACTCGCTTTTGGAGCTGAAG
SOCS2 Sense: CGACTAACCTGCGGATTGAGTA 80
Antisense: TGTCCGTTTATCCTTGCACA
Stat5a Sense: GTGAAGCCACAGATCAAGCA 174
Antisense: GTCAAACTCGCCATCTTGGT
Wap Sense: TATCATCTGCCAAACCAACG 185
Antisense: GGTCGCTGGAGCATTCTATC
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antibodies [1:300] for 30 min. Visualization of the bound biotin was
then performed using HRP-labeled streptavidin followed by DAB
substrate kit or Streptavidin–FITC followed by TOPRO staining (for
nucleus) according to manufacturer's protocol (Vector Laboratories).
The following rabbit polyclonal antibodies and dilutions were used
for immunoﬂuorescence: AQP5 at 1:100 (Alomone Labs), Npt2b at
1:50 (Alpha Diagnostic), NKCC1 at 1:1000 (gift from Dr. Jim Turner,
NIH), SMA at 1:250 (Sigma), (Abcam) and Stat5a at 1:100 (Santa Cruz
Biotechnology). Mouse monoclonal anti-β-catenin antibody (1:500,
Sigma) was used to visualize cell membranes. Antigen retrieval was
performed either in 1 mM EDTA (pH 8.0) for 15 min or in 10 mM
sodium citrate (pH 6.0) for 10 min. After blocking with M.O.M. kit
(Vector Laboratories), sections were incubated with primary anti-
bodies overnight at 4 °C, followed by 45-min incubation with Alexa
Fluor 568-conjugated anti-rabbit antibodies (1:750, Molecular
Probes) and FITC-conjugated anti-mouse antibodies (1:500, BD
Biosciences). The slides were mounted with Vectashield (Vector
Laboratories), and the immunoﬂuorescence was viewed under a
Nikon microphoto-FXA microscope (Nikon) or Leica Confocal
Microscope.
Protein extraction and Western blot analysis
Protein extracts from primary epithelial cell cultures were made in
RIPA buffer [50 mM Tris, 150 mM NaCl, 1 mM EDTA, 1%(v/v) Triton X-
100, 1%(w/v) sodium deoxycholate, 0.1%(v/v) SDS] supplemented
with complete protease inhibitor cocktail tablet (Roche) and phos-
phatase inhibitors (sodium orthovanadate (1 mM) and sodium
ﬂuoride (10 mM)). Mammary gland protein extracts were prepared
by grinding tissue into a ﬁne powder in liquid nitrogen and
subsequently dissolving in RIPA buffer supplemented with complete
protease inhibitor cocktail tablet (Roche) and phosphatase inhibitors.
The lysates were centrifuged at 13,000 rpm for 15 min and the
supernatant was collected as extracted protein. Protein extracts were
separated by SDS-PAGE and then transferred to a PVDF (polyvinyli-
dene diﬂuoride) membrane (Bio-Rad). After blocking, the blots were
probed with primary antibodies followed by a second incubationwith
secondary antibodies [1:20,000 or 1:30,000] conjugated to HRP.
Primary antibodies were as follows: goat anti-Elf5 antibodies [1:1000]
(Santa Cruz Biotechnology), alpha casein antibody [1:2000] (gift from
Dr. Yuping Sun, Harvard University), Stat5a [1:2000] (Santa Cruz
Biotechnology), p-Stat5 [1:1000] (Cell Signaling), Cre [1:2000]
(Novagen). For loading control, the blots were also probed with
mouse anti-β-tubulin antibodies [1:5000] (Chemicon) and anti-
mouse IgG secondary antibody [1:40,000] conjugated to HRP. The
chemiluminescence detection of HRP-conjugated secondary antibo-
dies was performed using the LumiGLO Reserve Chemiluminescent
Substrate kit (KPL).
RT-PCR and real-time RT-PCR analyses
Total RNAs were isolated from the primary cell cultures in BM
matrix and the mouse mammary glands using TRIzol reagent
(Invitrogen) in accordance with the manufacturer's instructions and
then further puriﬁed by phenol/chloroform extraction. Subsequently,
the puriﬁed RNA was treated with TURBO DNA-free kit (Ambion) to
remove genomic DNA contamination. The treated RNA was reverse
transcribed into cDNA by using SuperScript II reverse transcriptase
(Invitrogen) according to the manufacturer's protocol. PCR ampliﬁca-
tion was carried out using speciﬁc primer set for mouse NKCC1 gene
(Table 1). β-Actin and HPRT (hypoxanthine-guanine phosphoribosyl-
transferase) were ampliﬁed as loading controls. As an internal negative
control, an RNA aliquot that has not been subjected to reverse
transcriptase treatmentwas also ampliﬁed to ensure that the ampliﬁed
PCR product did not arise from ampliﬁcation of contaminatinggenomic DNA. PCR cycling was performed using the following
conditions: denaturation at 94 °C for 4 min; 30 cycles of ampliﬁcation
with denaturation at 94 °C for 20 s, annealing at 48 °C for 30 s,
extension at 72 °C for 1 min; ﬁnal extension at 72 °C for 10 min.
AmpliﬁedPCRproductswere visualizedbyagarose gel electrophoresis.
Real-time RT-PCRwas performed on a Bio-Rad iCycler iQ Real Time
PCR system (Bio-Rad Laboratories) using iQ SYBR Green Supermix
(Bio-Rad Laboratories) or mouse RT2 Proﬁler PCR Array kit for JAK/
STAT signaling pathway-relevant genes (SuperArray). Sequences of
gene-speciﬁc primer pairs for real-time RT-PCR analyses are listed in
Table 1. 1 μl of diluted cDNA, 12.5 μl of 2× SYBR Green Supermix and
speciﬁc primers in a total of 25 μl were ampliﬁed with the following
protocol: 1 cycle at 50 °C for 2 min, 1 cycle at 95 °C for 8.5 min, and 40
cycles at 95 °C for 15 s/60 °C for 1 min. The speciﬁc primer sets were
used at a ﬁnal concentration of 0.2 μMeach. For RT2 Proﬁler PCR Array,
RT2 First strand kit and RT2 SYBR Green/Fluorescein qPCR master mix
were used. Brieﬂy, 1 μg of total RNA was treated with Genomic DNA
elimination mixture at 42 °C for 5 min and chilled on ice immediately
for at least 1 min. Then, the RNA was reverse transcribed into ﬁrst-
strand cDNA using RT cocktail at 42 °C for 15 min. After reverse
transcription, the reactionwas heated at 95 °C for 5min to degrade the
RNA and to inactivate the reverse transcriptase. The resulting cDNA
synthesis reactionwas used for performing real-time PCR in RT2 qPCR
master mix cocktail. All real-time RT-PCR assays were performed in
duplicate in at least three independent experiments using two
different tissue sets. The iCycler software was used to calculate
threshold cycles. Relative expression value of each target gene was
normalized to β-actin or Gapdh gene expression.
ChIP assay for Elf5 occupancy
Mouse mammary glands (fourth and ﬁfth) at pregnancy day 17.5
were excised in aseptic conditions and minced in PBS. The tissue
231Y.S. Choi et al. / Developmental Biology 329 (2009) 227–241fragments were resuspended in 4 ml of PBS and crosslinked for 5 min
at RT by adding formaldehyde (Sigma-Aldrich, St. Louis, MO) to a ﬁnal
concentration of 1%. The crosslinking reaction was stopped by adding
glycine (Sigma-Aldrich, St. Louis, MO) to a ﬁnal concentration of
125 mM and incubating for 5 min at room temperature. The tissue
fragments were recovered by centrifugation for 10 min at 3000 ×g.
Then, they were rinsed thrice with 8 ml of cold PBS and the tissue
fragments were resuspended in cold cell lysis buffer (10 mM Tris–HCl,
pH 8.0, 10 mM NaCl, 3 mM MgCl2, 0.5% NP-40) containing 1× of
Protease Arrest (G-Biosciences, St. Louis, MO) and transferred to a cold
Dounce homogenizer (Rubins et al., 2005). After complete homo-
genization of the tissue, the nuclei were pelleted by centrifugation for
5 min at 12,000 ×g. Nuclei were lysed in 750 μl of ChIP lysis buffer
(ChIP kit, Upstate, Charlosttesville, VA) and sonicated 16 times with
15-second cycles at setting 3 (Branson Soniﬁer 250) to generate
fragments of 0.5 kb on average. Sonicated samples were centrifugated
at 12,000 ×g for 10 min and the supernatant was transfer to a new
tube. Aliquots of 180 μl were diluted 10-fold in ChIP dilution buffer
(EZ-ChIP kit, Millipore, Temecula, CA) then, pre-cleared by incubating
with 75 μl of 50% protein G-Sepharose beads slurry containing salmon
sperm DNA and BSA (EZ-ChIP kit, Millipore, Temecula, CA) at 4 °C for
30 min. The pre-cleared chromatin was divided in aliquots of 600 μl
and they were immunoprecipitated overnight at 4 °C with 10 μg of
anti-Elf5 (N-20) (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) or
normal goat IgG (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) or no
antibody as control. The immunoprecipitation, washing, elution,
reversing crosslink and proteinase K treatment were performed
according to the manufacturer's directions described in the EZ-ChIP
kit (Millipore, Temecula, CA). After proteinase K treatment, the
immunoprecipitated DNA was puriﬁed with PCR puriﬁcation kit
(QIAGEN, Inc. Valencia, CA). PCR analysis for Elf5 occupancy in the
proximal promoter of Stat5a was performed in a volume of 25 μl
containing1×PCRbuffer (Sigma-Aldrich, St. Louis,MO), 200 μMdNTPs
(Sigma-Aldrich, St. Louis, MO), 2 ng/μl of each P1 (CAGGAACTCG-
GAATGGAAAG) and P2 (GGAGCTTTGCCTGGATCATA) primers, P3
(GAGCTGACACCCTCAAGGTC) and P4 (CTGGAGGGATTTTGAGCAAG)
primers, 1.25 U Jumpstart Taq DNA polymerase (Sigma-Aldrich, St.
Louis,MO) and5 μl template. The PCRswere carried out 95 °C for 4min,
followed by 35 cycles of 95 °C for 45 s, 58 °C for 45 s and 72 °C for 45 s,
with a ﬁnal extension step at the end of 72 °C for 5 min. The PCR
ampliﬁcation products were analyzed by gel electrophoresis in a 1.5%
agarose gel in 1× TBE buffer at 120 V for 50 min and visualized with
ethidium bromide staining and pictures were taken.
Results
Conditional deletion of exon 6 leads to functional inactivation of Elf5
Since the early embryonic lethality of the conventional knockout
precluded studying the role of Elf5 in the development of adult
epithelial cells, we employed the Cre–loxP recombination system to
generate conditional Elf5 knockout mice. In these animals containing
the ﬂoxed allele (hereafter referred to as Elf5f/f mice), the loxP sites
ﬂank exon 6, which encodes formost of the Ets domain of the Elf5 gene
(Fig.1A and Fig. S1A, available as supplemental material). The deletion
of the Ets domain is very likely to disrupt the critical biological
functions of Elf5 protein since the Ets domain is the DNA binding
domain necessary for transcriptional activity of Elf5 (Sharrocks, 2001).
As shown by Southern blot analyses, the knockout strategy led to the
expected rearrangements in the Elf5 genomic locus (Fig. S1B). Elf5f/f
mice developed normally and were phenotypically indistinguishable
from their wild-type littermates. Since the Elf5f/f animals harbored a
phosphoglycerate kinase-neomycin (PGK-neo) cassette we alsomated
the Elf5f/f animals with ﬂipper (FLPe) mice to remove the PGK-neo
cassette and one FLPe recognition target (FRT) site, leaving behind two
loxP sites ﬂanking exon 6 (Fig. S1A). The FLPe-mediated excision of thePGK-neo cassette was veriﬁed using Southern blot analysis (Fig. S1C).
Mice having two deleted alleles generated by the FLPe recombinase
displayed no overt phenotypic abnormalities, indicating that the
introduction of a PGK-neo cassette and two FRT sites had no adverse
effect on the transcriptional regulation of Elf5.
To investigate the role of Elf5 in the mammary gland epithelium,
the Elf5f/f mice were bred ﬁrst with the well-characterized mouse
mammary tumor virus (MMTV)-Cre transgenic mice, which express
Cre in luminal epithelium of themammary gland (Wagner et al., 2001;
Wagner et al., 1997). Although MMTV-Cre/Elf5+/f animals were born
in normal Mendelian ratios, very few MMTV-Cre/Elf5f/f mice
survived. However, in the animals that survived, targeted deletion of
Elf5 by the MMTV-Cre transgene resulted in severe lactation defects in
MMTV-Cre/Elf5f/f females. Histological analysis showed poorly
developed mammary epithelial structures in the few MMTV-Cre/
Elf5f/f females that were examined (Fig. S2). To overcome the lethality
associated with MMTV-Cre/Elf5f/f animals we crossed the Elf5f/f
animals with K14-Cre transgenic animals. We ﬁrst examined the
efﬁciency and speciﬁcity of K14-Cre-mediated recombination in
mammary gland by crossing K14-Cre transgenic mice with ROSA26-
LacZ reporter mice, and the LacZ (β-galactosidase) staining was
observed in both luminal and myoepithelial cells (Fig. 1B). This
observation is consistent with the fact that K14 promoter is active in a
common progenitor cell type, which can commit to either luminal or
myoepithelial cells (Dunbar et al., 2001; Woodward et al., 2005).
In contrast to MMTV-Cre/Elf5f/f animals, K14-Cre/Elf5f/f mice
containing two ﬂoxed Elf5 alleles and K14-Cre transgene were
obtained at the expected frequency from all crosses, viable and fertile.
All mice of K14-Cre/Elf5+/+, K14-Cre/Elf5+/f and K14-Cre/Elf5f/f
reached puberty with no obvious phenotypic abnormalities. Exam-
ination of the skin samples by PCR showed that the Cre-mediated
recombination events indeed took place as expected with the deletion
of exon 6 in K14-Cre/Elf5+/f and K14-Cre/Elf5f/f animals (Fig. 1C). To
conﬁrm Elf5 deletion in mammary gland tissue, the level of Elf5
protein in the mammary gland was measured by Western blot
analysis. As shown in Fig. 1D, Elf5 protein expression was signiﬁcantly
reduced in K14-Cre/Elf5+/f mammary gland and completely lost in
K14-Cre/Elf5f/f mammary gland tissues at parturition. The absence of
Elf5 protein in K14-Cre/Elf5f/f mammary glands indicates that the
targeting event has successfully generated a null mutation of Elf5 in
mammary gland tissue. Interestingly, though Elf5 is highly expressed
in skin epithelium, primarily in the hair follicles, K14-Cre-mediated
deletion of Elf5 resulted in no apparent skin phenotype. However,
both K14-Cre/Elf5+/f and K14-Cre/Elf5f/f females displayed dramatic
defects in mammary gland development during pregnancy and
lactation. The K14-Cre-mediated Elf5 mutant dams gave birth to
pups whose size and numbers were normal. However, all pups
suckling on the Elf5 mutant mothers, regardless of their genotype,
diedwithin a couple of days of birth. Examination of the pups revealed
no milk in the stomach suggesting an inability of the Elf5 mutant
mothers to lactate or nurse.
Elf5 is indispensable for mammary lobuloalveolar development
The fact that primiparous Elf5-deﬁcient dams are unable to feed
their pups suggested defects in alveologenesis and lactogenesis. To
evaluate this we harvested mammary glands on the day after
delivery of pups from wild-type, K14-Cre/Elf5+/f and K14-Cre/Elf5f/f
females. Differentiation status of Elf5-deﬁcient mammary tissue at
parturition was strikingly different from that of wild-type counter-
part, as judged by whole-mount and histological analyses (Fig. 2).
During terminal differentiation, wild-type mature mammary ductal
tree is decorated with well-differentiated lobuloalveolar units
consisting of fully expanded alveoli ﬁlled with milk (Figs. 2A–C).
However, a fairly low density of lobuloalveoli-like structures was
observed in K14-Cre/Elf5+/f mammary tissue, suggestive of defective
Fig. 2. Severely impaired lobuloalveolar development in Elf5-deﬁcient females. (A–C) K14-Cre/Elf5+/+; (D–F) K14-Cre/Elf5+/f; (G–I) K14-Cre/Elf5f/f mammary glands from
primiparous dams on the day after delivery of pups. (A, D and G) Whole-mount analysis of mammary glands by carmine alum staining. (B, C, E, F, H and I) Histological analysis of
mammary gland tissue sections by hematoxylin and eosin staining. Dilated ducts are indicated by the arrows in E. Black arrowheads indicate the presence of cytoplasmic lipid
droplets (C and F). Red arrowhead denotes accumulated luminal secretory materials (F). Note that Elf5-null mammary tissues exhibit closed lumina and no lobuloalveoli (I). A
representative specimen is shown as example in each case; the experiments were performed ﬁve times independently and yielded similar results (n=5 for each genotype). Bar in A,
B, D, E, G and H, 0.5 mm. Bar in C, F and I, 100 μm.
232 Y.S. Choi et al. / Developmental Biology 329 (2009) 227–241differentiation (Figs. 2D–F). In addition, only minority of lumina
displayed features of secretory differentiationwith lipid droplets (Fig.
2F, black arrowhead), whereas most alveolar lumina were ﬁlled with
condensed luminal secretory materials (Fig. 2F, red arrowhead).
Accumulation of luminal secretory materials normally appears during
midpregnancy in undifferentiated alveolar epithelium. Therefore, the
retention of luminal secretory materials in K14-Cre/Elf5+/f mammary
alveoli at parturition further implies that the K14-Cre/Elf5+/f
mammary epithelial cells fail to undergo terminal differentiation.
Histological analysis also showed large lobuloalveolar units composed
of many individual alveoli that were lined by ﬂattened, vacuolated
epithelial cells in wild-type mammary tissue sections (Fig. 2C). In
contrast, the K14-Cre/Elf5+/f mammary tissue was still mostly
composed of adipose stroma and the parenchyma consisted of dilated
ducts (Fig. 2E, black arrow) and small clusters of alveoli-like structures
that were lined by packed cuboidal epithelial cells (Fig. 2F). While the
histological features of K14-Cre/Elf5+/f mammary tissue at parturitionwere partially reminiscent of immature alveoli of wild-type, the
defects in the mammary epithelial cells in K14-Cre/Elf5f/f mice were
more pronounced (Figs. 2G–I). Notably, whole-mount and histological
analyses revealed that K14-Cre/Elf5f/f mammary tissue did not have
the appearance of lobuloalveoli-like structures and were completely
underdeveloped. While in postpartum mammary tissue of wild-type
mice, adipose tissue was replaced by lobuloalveolar structures, the
K14-Cre/Elf5f/f mammary tissue was largely composed of adipocytes
and its fat pad was almost entirely ﬁlled with ducts. Interestingly, the
majority of K14-Cre/Elf5f/f epithelial architecture at parturition
consistently exhibited closed lumen (Fig. 2I). Interestingly, this defect
in K14-Cre/Elf5f/f mothers was consistently exhibited even after
multiple pregnancies, indicating that the complete loss of Elf5 could
not be compensated by multiple exposures to pregnancy (Fig. 3A).
Unlike K14-Cre/Elf5f/f dams, primiparous K14-Cre/Elf5+/f females
consistently failed to lactate but multiparous K14-Cre/Elf5+/f
females often were able to lactate. As shown in Fig. 3B, the partial
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immature lobuloalveoli at the ﬁrst pregnancy, while the lactating
mammary glands, which were restored after multiple pregnancies
displayed fully expanded alveoli containing lipid droplets. The
successful lactation after numerous pregnancies could be partially
explained by a cell population that might have survived through
involution (Brisken et al., 1999).
Elf5-null mammary epithelium at parturition retains characteristics of
virgin ductal epithelial cells
To identify the epithelial cells lacking Elf5 at parturition as ductal or
alveolar, we investigated the expression of speciﬁc markers. First, Elf5-
deﬁcient mammary glands were evaluated by immunoﬂuorescence
staining of ductal markers, AQP5 and Na–K–Cl cotransporter 1
(NKCC1). Normally, NKCC1 and AQP5 are present at high levels in the
ductal epithelial cells of virgin mammary gland and there is a
diminution of NKCC1 and AQP5 levels during pregnancy and at
parturition (Shillingford et al., 2002; Shillingford et al., 2003). Our
immunostaining studies showed that AQP5 and NKCC1 expression
persisted in postpartum Elf5-deﬁcient mammary epithelia (white
arrowhead in Figs. 4D, E, G. H), while it was undetected in lactating
wild-type mammary tissue (Figs. 4A and 4B). The retention of
signiﬁcantly high levels of NKCC1 mRNA in Elf5-deﬁcient mammary
glands at parturition further supports this observation (data not
shown).Fig. 3. Restoration of lactation in K14-Cre/Elf5+/f dams after multiple pregnancies. (A) Percen
n=5), uniparous K14-Cre/Elf5+/f (0%; n=14), biparous K14-Cre/Elf5+/f (33%; n=16), t
females. Black color space in a pie chart represents the proportion of the total number of fem
were unable to lactate. (B) Histological analysis of lactating mammary tissue in K14-Cre/E
restored biparous (right panel) females on the day after delivery of pups were stained w
impaired mammary alveoli, while restored multiparous K14-Cre/Elf5+/f females have fullyThe Na–Pi cotransporter isoform, Npt2b is expressed on the apical
membrane of secretory alveolar epithelium in lactating mammary
gland and serves as a marker of secretory function (Shillingford et al.,
2002; Shillingford et al., 2003). The absence of Npt2b protein at
parturition is indicative of a lack of secretory function (Miyoshi et al.,
2001). As expected, the apical membranes of secretory alveoli in wild-
typemammary glands stained intensely for Npt2b (Fig. 4C). The alveoli
in K14-Cre/Elf5+/f mammary glands displayed a mosaic staining
pattern of Npt2b at parturition with expression evident only on the
apicalmembrane of a few secretory cells (Fig. 4F,white arrowhead) and
was absent from most alveoli-like structures (Fig. 4F, yellow arrow-
head). In contrast, apical Npt2b expression was not at all detectable in
K14-Cre/Elf5f/f mammary tissues at parturition, indicating a critical
defect in terminal epithelial differentiation (Fig. 4I). Interestingly, in the
Elf5 knockout mammary gland, apart for the usual basolateral surfaces,
NKCC1 staining also was observed in the apical surface of some
population (20–30%) of epithelial cells implying that Elf5-deﬁcient
luminal epithelial cells fail to properly polarize (Figs. S3 A–C, yellow
arrowhead). This defect in cell polarity is further evident with the
aberrant staining pattern for Laminin, a basal marker, which shows
distinct localization of laminin in the basolateral sides of luminal
epitheliumof Elf5-deﬁcientmammaryglands at parturition (Figs. S3D–
F, yellow arrowhead) similar to those observed in MMTV-β1-integrin
transgenicmice (Faraldo et al.,1998).Wehypothesize that this defect in
the cellular polaritymight be the partial underlying cause for the closed
lumen structures observed in the K14-Cre/Elf5f/f mammary glands.tage of animals capable of lactationwas determined from triparous K14-Cre/Elf5f/f (0%;
riparous K14-Cre/Elf5+/f (56%; n=9) and uniparous K14-Cre/Elf5+/+ (100%; n=5)
ales capable of lactation. Note that all uniparous and biparous K14-Cre/Elf5f/f females
lf5+/f females. Mammary gland sections from the ﬁrst pregnant (left panel) and the
ith hematoxylin and eosin. At parturition, primiparous K14-Cre/Elf5+/f females show
expanded alveoli containing lipid droplets. Bar, 100 μm.
Fig. 4. Failure of alveolar differentiation in K14-Cre/Elf5f/f mammary gland. All mammary glands were harvested from females on the day after delivery of pups. Immunoﬂuorescence
staining of AQP5 (red; A, D, G), NKCC1 (red; B, E, H) and Npt2b (red; C, F, I). β-Catenin (green) was normally expressed in the basolateral membrane of tissue sections examined, and
was used to visualize cell membranes (A, C, D, F, G, I). SMA (smooth muscle actin, green) was used to label the myoepithelial cells (B, E, H). White arrowheads in D and G and E and H
indicate retained expression of AQP5 andNKCC1 in the Elf5-deﬁcient mammary epithelium in comparison to thewild-type (A and B). Some occasional cells show staining of NKCC1 in
thewild-typemammary epithelium as indicated by awhite arrowhead (B).White arrowhead in C indicates Npt2b staining of the apical surface of thewild-type secretory epithelium.
Yellow arrowheads pointed to the absence of Npt2b expression in alveoli-like structures (F). Note no positive Npt2b staining in K14-Cre/Elf5f/f mammary tissue (I). Bar, 100 μm.
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of NKCC1 and AQP5 in mammary glands lacking Elf5 suggested that
the characteristic features of virgin ductal epithelial cells persisted in
Elf5-null mammary epithelium at parturition, most likely due to
failure of ductal epithelial cells to undergo cellular speciﬁcation to
secretory alveolar cells accompanied by alterations in cellular polarity
and orientation.
Reduced proliferation of Elf5-null mammary epithelium associated with
persistence of estrogen receptor alpha (ERα) and progesterone receptor
(PR) positive cells
Proliferation of mammary alveolar epithelium occurs throughout
pregnancy and during early postpartum period.We used Ki67 staining
to determine whether defective alveolar development in Elf5-
deﬁcient mice was a result of impaired proliferation. When comparedto a K14-Cre/Elf5+/+ mammary gland at the same developmental
time periods, a signiﬁcant reduction in Ki67 positive epithelial cells
was observed in K14-Cre/Elf5f/f mammary tissue (Figs. 5A, D)
suggesting that reduced proliferation might partly contribute to the
defects in lobuloalveolar development along with defective differ-
entiation of secretory cells.
Cell proliferation in the mammary gland is under the control of
multiple hormones and their effectors such as the ERα and PR. While
luminal cells of a virgin mammary gland and early pregnancy exhibit
an abundant presence of ERα and PR, during late pregnancy and
lactation stages expression of these receptors is downregulated (Figs.
5B, C). To test if the failure of alveolar cells to proliferate was also
associatedwith aberrant hormone response statewe stained K14-Cre/
Elf5f/f mammary tissue for ERα and PR. As expected, expression of ERα
and PRwas retained in the Elf5-deﬁcient luminal cells during lactation
in accordance with the reduced proliferation state (Figs. 5E, F).
Fig. 5. K14-Cre/Elf5f/f mice exhibit defects in mammary epithelial proliferation. Immunohistochemical detection of Ki67 in K14-Cre/Elf5+/+mammary epithelium (A) and K14-Cre/
Elf5f/f mammary epithelium (D). A signiﬁcant reduction in the percentage of Ki67 positive cells was observed in K14-Cre/Elf5f/f mammary epithelium. Immunohistochemical
staining with PR and ERα show retained expression of PR and ERα in K14-Cre/Elf5f/f epithelium (E and F) compared to wild-type mammary epithelium (B and C). Bar, 40 μm.
235Y.S. Choi et al. / Developmental Biology 329 (2009) 227–241Elf5-null mammary epithelium lacks activated Stat5 and fails to undergo
functional differentiation
It has been previously shown that ectopic expression of Elf5 can
rescue the impaired alveologenesis of mammary tissue lacking PrlR,
implying that Elf5 would be involved in the prolactin-mediated
mammary differentiation (Harris et al., 2006). The PrlR/Jak2/Stat5
signaling has been well known to regulate mammary gland develop-
ment during pregnancy and lactation (Brisken and Rajaram, 2006;
Hennighausen and Robinson, 2005; Miyoshi et al., 2001; Oakes et al.,
2006). Immunohistochemistry of Elf5 in wild-type mammary tissue
showed that the nuclei of most luminal cells were uniformly positive
for Elf5 (Fig. 6A). However, the Elf5 in K14-Cre/Elf5+/f mammary
tissue was expressed in a mosaic pattern (Fig. 6E) and complete
ablation of Elf5 expression was conﬁrmed in K14-Cre/Elf5f/f mam-
mary epithelium (Fig. 6I). To determine whether alterations in PrlR/
Jak2/Stat5 signaling pathway are responsible for the failed lobuloal-
veolar development in Elf5-null mice, we ﬁrst analyzed the expression
levels of PrlR, Janus kinase 2 (Jak2) and signal transducer and activator
of transcription 5 (Stat5), which are involved in tyrosine phosphor-ylation and activation of Stat5 protein. Quantitative RT-PCR analyses
indicated that while PrlR and Jak2 levels were unchanged, Stat5a
levels were decreased in Elf5-deﬁcient mammary glands compared
with wild-type counterparts (Fig. S4). The reduced expression of
Stat5a in Elf5-deﬁcient mammary tissue was further veriﬁed in terms
of protein expression by immunoﬂuorescence staining of Stat5a.
While a strong signal for Stat5a was detected in most alveolar cells of
wild-type mammary epithelia (Fig. 6B), fewer Stat5a-positive cells
were detected in Elf5-mutant epithelia (Figs. 6F, J). In addition, a
monoclonal antibody, which is speciﬁc to tyrosine (Y694) phosphory-
lated Stat5 (p-Stat5), was used to detect the activated Stat5 proteins.
As expected, prominent nuclear staining of p-Stat5 was uniformly
observed in mammary alveolar cells of wild-type mice at parturition
(Fig. 6C). However, K14-Cre/Elf5+/f mammary tissue at parturition
displayed a mosaic pattern of p-Stat5 expression (Fig. 6G), consistent
with the Elf5 expression pattern observed in heterozygous Elf5
mutant mammary tissue. Strikingly, despite the normal expression
of PrlR and Jak2, p-Stat5 was almost completely suppressed in the
Elf5-null mammary epithelial cells at parturition (Fig. 6K). Although
our analyses showed reduced Stat5a expression in Elf5-null mammary
Fig. 6. Downregulation of p-Stat5 and the absence of Wap in Elf5-null mammary gland at parturition. All mammary tissues were harvested from females on the day after delivery of
pups. (A–L) Immunostaining of Elf5, Stat5a, p-Stat5 andWap in mammary tissues of primiparous K14-Cre/Elf5+/+ (A–D), K14-Cre/Elf5+/f (E–H) and K14-Cre/Elf5f/f (I–L). Sections
were stained with anti-Elf5 (A, E and I), anti-Stat5a (red; B, F and J), anti-β-catenin (green; B, F and J), anti-p-Stat5 (C, G and K) or anti-Wap (D, H and L) antibodies. Positive staining
for Elf5 or p-Stat5 is noted in the nuclei of luminal cells and Wap-positive staining is shown in the lumina and the luminal border. Note that Elf5-null mammary tissues display no
positive Elf5 (I) andWap (L) staining and very few positive staining with Stat5a (J) and p-Stat5 (K, arrowhead). A representative specimen is shown as an example in each case; the
experiments were performed three times independently and yielded similar results (n=3 for each genotype). Bar, 100 μm.
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regulation of Stat5a gene expression in mammary epithelial cells since
considerable levels of Stat5a were still maintained in Elf5-null
epithelia. It also does appear that the extent of p-Stat5 down-
regulation was more than what could be explained by that reduced
levels of Stat5a suggesting that additional pathways involved in Stat5phosphorylation may be compromised. We also examined the
phosphorylation status of Stat5 in the mammary glands of K14-Cre/
Elf5f/f at postpuberty (12 week virgin), midpregnancy (P12.5) and late
pregnancy (P17.5). Immunostaining indicated reduced staining of p-
Stat5 that was pronounced in P12.5 and P17.5 samples of K14-Cre/
Elf5f/f mammary glands (Fig. S5). Western blot analysis on enriched
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the reduced expression of p-Stat5 compared to the K14-Cre/Elf5+/+
samples (data not shown). Taken together, these data raise an
interesting possibility that Elf5 can not only modulate the PrlR/Jak2-
mediated activation of Stat5 but also can regulate Stat5 transcription
in mammary epithelial cells.
To examine the functional differentiation status in Elf5-null
mammary epithelium, we determined expression of whey acidic
protein (Wap) which is a major milk protein in mice. Wap is known to
be regulated by Elf5 and/or Stat5 transcription factors since the
binding sites for Elf5 or Stat5 are found within Wap promoter regions
(Derbinski et al., 2008; Rosen et al., 1999; Thomas et al., 2000).
Immunohistochemistry of Wap showed a striking difference in milk
production between Elf5 mutant and wild-type mammary glands. As
predicted, theWap proteinwas highly abundant in secretory alveoli of
lactating wild-type mammary glands (Fig. 6D). In contrast, weak
expression of Wap was observed in K14-Cre/Elf5+/f mammary tissue
(Fig. 6H) and the Elf5-null mammary epithelia lacking p-Stat5
completely failed to express Wap protein at parturition (Fig. 6L).
These data were conﬁrmed by Western blot analysis of Wap
expression (data not shown). These results clearly demonstrate that
mammary epithelial cells do not undergo functional differentiation/
lactogenesis in the absence of Elf5 and that the absence of activated
Stat5 may contribute to this phenotype.
Loss of Elf5 leads to transcriptional downregulation of genes involved in
alveolar development
In an effort to gain further insight into the molecular mechanisms
underlying the Elf5-mediated alveolar development, we sought to
examine potential target genes of Elf5. For this purpose we focused
our attention to two distinct groups of molecules: ones that are part of
the broader Jak/Stat pathway and others that have been implicated in
alveolar homeostasis based on genetic and/or biochemical evidence.
Quantitative RT-PCR analyses of the mammary glands lacking Elf5
(either homozygous or heterozygous) revealed that expression of
many of such genes involved in alveolar development were altered
while compared with the wild-type mammary glands. Changes in
selected transcripts are shown in Fig. 7. Unlike the reduced Stat5a
expression levels in the K14-Cre/Elf5f/f mammary glands, mRNA
expression levels of other Stat family members were comparable toFig. 7. Elf5-mediated gene regulation in mammary alveolar development. Gene expression
mice at parturition. The real-time RT-PCR assays were performed in at least three independthose of wild-type counterparts (data not shown). We also examined
the Suppressor of cytokine signaling (SOCS) family, since SOCS
members negatively regulate the PrlR/Jak2-mediated activation of
Stat5 (Starr et al., 1997; Tomic et al., 1999). Interestingly expression of
two such SOCS genes, SOCS2 and SOCS3 was signiﬁcantly upregulated
in mammary tissue lacking Elf5 (Fig. 7).
Quantitative RT-PCR analysis showed that the Id2 (inhibitor of DNA
binding 2), IKKα (inhibitor of kappa B kinase alpha) and Lmo4 (LIM
domain only 4) mRNA expression were all downregulated three- to
four-fold in postpartum Elf5-null mammary gland (Fig. 7). Interest-
ingly, these genes are known to play important roles in alveolar and
lactogenic differentiation as demonstrated bymouse knockout studies
(Cao et al., 2001; Desprez et al., 2003; Miyoshi et al., 2002; Mori et al.,
2000; Sum et al., 2005). Other signiﬁcant changes inmRNA expression
levels were observed in cytokeratin 18 (K18), mucin 1 (Muc-1) and
claudin 7 (Cldn7). The intermediate ﬁlament protein K18, transmem-
brane glycoprotein Muc-1 and membrane-associated protein Cldn7
are expressed in mammary luminal epithelial cells (Blackman et al.,
2005; Hilkens et al., 1992; Mikaelian et al., 2006) and their reduced
expression might reﬂect the reduction in the epithelial compartment
in Elf5 null mammary gland (Fig. 7). It has been shown that Elf5 can
transcriptionally upregulate K18 expression in lung epithelial cells by
interactingwith putative Elf5 binding sites located in the ﬁrst intron of
K18 (Yaniw and Hu, 2005); we speculate that this mechanism may
also be operative in mammary epithelial cells. In addition, Cldn7 has
been reported to be reduced in PrlR-deﬁcient mammary tissue
(Ormandy et al., 2003), its reduction in Elf5 knockout animals most
likely reﬂects the fact that Elf5 is an important downstream
component of the PrlR signaling pathway. On the contrary, by
quantitative RT-PCR, we found no change in expression of β-catenin
(Fig. 7), an essential factor for alveolar cell survival (Tepera et al.,
2003), in agreement with immunoﬂuorescence staining with anti-β-
catenin antibodies in Elf5 null mammary tissue. The wide range of
critical genes altered by the loss of Elf5 suggests that these could be
potential targets of Elf5 in mammary gland development.
Elf5 is required for Stat5a expression and activation in cultured
mammary epithelial cells
To directly examine the role of Elf5 in regulating Prl signaling and
Stat5 activity and in governing the alveolar differentiation programweanalysis of mammary glands from K14-Cre/Elf5+/+, K14-Cre/Elf5+/f or K14-Cre/Elf5f/f
ent experiments using two different tissue sets. Data are presented as the mean±SD.
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cells (MECs). MECs were harvested from Elf5f/f mice and infectedwith
either Ad-Cre or Ad-GFP and cultured on BM matrix for varying time
points. Infection of MECs with adenovirus expressing Cre resulted in
signiﬁcant knockdown of Elf5 expression by 48 h after infection (data
not shown) with virtually no detectable protein after 72 h (Figs. 8A
and B). Interestingly, Ad-Cre-infected cells showed no apparent
abnormal morphological phenotype and formed mammary organoids
similar in size and appearance to the control Elf5f/f cells (Fig. S6) when
observed after 72 h. To examine Stat5 activity, MECs were grown for
24 h in growth media and then cultures were exposed to differentia-
tion media containing prolactin for another 48 h. Protein lysates were
harvested from differentiated MECs and Western blots were
performed. Concomitant with the loss of Elf5 in Ad-Cre-infected
Elf5f/f MECs, there was a signiﬁcant reduction in the expression of
Casein, suggesting that Elf5 null cells fail to differentiate. Similarly,
there was a modest decrease in the overall levels of Stat5a, but a
dramatic reduction in the levels of p-Stat5 (Fig 8B). This data
corroborates our in vivo ﬁndings from K14-Cre/Elf5f/f mice and
suggest that the acute loss of Elf5 not only leads to decreased
expression of Stat5a but also causes an even more profound effect on
Stat5 activity by regulating its phosphorylation status.Fig. 8. Elf5 regulates prolactin-mediated differentiation and Stat5 activity. (A) Elf5f/f p
suspension and plated on BM matrix. Western blot analysis of protein lysates from Elf5f/f
containing prolactin (A) and (B). (B) The loss of Elf5 also blocked differentiation as demon
of MECs from control and Elf5f/f mice infected with Ad-Cre at 72 h. The real-time RT-PCR
the absence of Elf5, milk proteins like Wap, α casein and β casein are down regulated. Lo
and SOCS3 transcripts. Changes in Id2 and Cldn7 levels were not statistically signiﬁcant.Having established the Elf5-null MEC system, we next investigated
whether the loss of expression of some of the critical mediators
described in Fig. 7 in the Elf5-null mammary glands is due to a direct
transcriptional event mediated by Elf5 or merely indicative of the
block in differentiation phenotype. We performed Quantitative RT-
PCR analyses of the primary cultures lacking Elf5 (Ad-Cre-Elf5f/f) to
examine the expression levels of some of the genes as shown in Fig.
8C. Interestingly both Stat5a and Wap transcripts were signiﬁcantly
downregulated in Ad-Cre-Elf5f/f compared to (Ad-GFP-Elf5f/f) cells. In
agreement with the data obtained from Elf5-null mammary glands,
expression of SOCS2 and SOCS3 was signiﬁcantly upregulated in Elf5-
deleted MECs. However, some of the transcripts such as Id2 and Cldn7
did not show any signiﬁcant change suggesting that these might
reﬂect indirect effects of the loss of Elf5 in mammary glands.
Stat5 is a direct transcriptional target of Elf5
Having established Stat5 as a potential downstream target of Elf5,
we wondered if Elf5 directly regulates the expression of Stat5. To
address this, we searched for Elf5-response elements (Elf5RE) in the
proximal promoter region of Stat5 based on sequence similarities to
the Elf5 consensus site as deﬁned by our laboratory (Choi and Sinha,rimary mammary epithelial cells (MECs) were infected with Ad-GFP or Ad-Cre in
MECs infected with Ad-Cre resulted in knockdown of Elf5 in differentiation medium
strated by decreased levels of Casein, Stat5a and p-Stat5. (C) Gene expression analysis
assays were performed in duplicates using three independently generated samples. In
ss of Elf5 also led to reduced expression of Stat5a mRNA and up-regulation of SOCS2
Fig. 9. ChIP analysis for Elf5 occupancy in the proximal promoter of Stat5a in mouse mammary gland. (A) Schematic diagram of the proximal promoter of mouse Stat5a gene showing
the location of the primers (P1 and P2) that were used to amplify the region that contains a putative Eﬂ5 binding site. A region 3′ of the Stat5 genewas also ampliﬁed using primers P3
and P4 as a negative control. The location of the transcription start site (TSS) is also indicated. (B) Sequence fragments of Stat5a proximal promoter from various species were
obtained from Ensemble genome database and aligned using the ClustalW2 software. The ⁎ sign indicated conserved residues. The line shows the putative Elf5 binding sites (with a
GGAA core) and the arrow indicates the putative TSS. (C) Elf5 occupancy by ChIP analysis using the primer combination P1/P2 and P3/P4 in whole tissue of mouse mammary gland
(pregnancy day 17.5) with anti-Elf5 and as well as with normal goat IgG or without any antibody as indicated. The PCR ampliﬁcation of the input represents 1% of the chromatin DNA
used for the ChIP. Results are representative of three independent experiments.
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element close to the transcriptional start site of the mouse Stat5 gene
showed the highest level of sequence similarity between several
species (Figs. 9A and 9B). The evolutionarily conserved nature of the
Elf5RE suggested the possibility of a functionally important role for
this DNA element. We next veriﬁed whether Elf5 was able to interact
with the promoter of the Stat5 gene in vivo, by performing ChIP
(Chromatin immunoprecipitation) assays in mammary gland. For this
purpose we utilized a speciﬁc antibody against Elf5, that has been
shown to be effective in ChIP experiments as well as a control IgG
antibodies (Ng et al., 2008). As shown in Fig. 9C, our PCR data clearly
shows a speciﬁc ampliﬁcation of the Stat5 proximal promoter region
but not of a randomly selected genomic segment 3′ to the Stat5 gene
in Elf5-immunoprecipitated genomic DNA compared to the control
IgG antibodies. This suggests that Elf5 can directly interact with
regulatory regions of the Stat5 in mammary epithelium.
Discussion
To identify essential functions of Elf5 during mammary gland
development, we have generated the ﬁrst mammary gland-speciﬁc
Elf5 knockout mice utilizing the Cre–lox system. While some
phenotypic consequences of Elf5 deﬁciency in mammary glands
have been reported previously, embryonic lethality associated with
the complete loss of Elf5 have limited these studies to Elf5
heterozygotes or mammary transplants. These studies have estab-
lished that Elf5 plays an important role in lobuloalveolar development
and milk secretion and serves as a critical mediator of the prolactinhormonal pathway. Our results described in this report extend these
prior observations and provide new mechanistic insights into the
function of Elf5 as an essential modulator of PrlR/Jak2-mediated
activation of Stat5 and a master regulator in alveolar and lactogenic
development.
In agreement with prior studies, we document that the critical role
of Elf5 is during alveologenesis since in its absence, there is a complete
block in this stage of mammary gland development. Thus Elf5-null
mammary epithelium at parturition retains characteristics of virgin
ductal epithelial cells with persistence of marker proteins NKCC1 and
AQP5 and a failure of induction of Np2tb. In glandular epithelia such as
the mammary gland, establishing proper basoapical polarity axis such
that the basal surface of the cells is against the extracellular basement
membrane, and the apical surface is next to the lumen, is of
paramount importance in maintaining functional differentiation. In
the absence of Elf5, we ﬁnd that a subpopulation of luminal cells
exhibit an aberrant polarity—with an altered localization of surface
marker proteins such as Laminin and NKCC1. Furthermore, we also
observe reduced proliferation of Elf5-null mammary epithelium
associated with persistence of estrogen receptor alpha (ERα) and
progesterone receptor (PR) positive cells, a phenomenon also
observed in other knockout models associated with blocked lobu-
loalveolar development (Grimm et al., 2002). The reduced prolifera-
tive potential of Elf5 null cells along with their altered cellular
orientation may signiﬁcantly contribute to the block in lobuloalveolar
development along with defective differentiation of secretory cells.
Not surprisingly, the severely defective alveoli-like structures
observed in K14-Cre/Elf5f/f mammary glands are reminiscent of
Fig. 10. Prospective model explaining the effect of Elf5 on alveolar and lactogenic
differentiation. In the absence of Elf5, Stat5 expression is reduced and SOCS2 and SOCS3
expression are upregulated. These events lead to downregulation of PrlR/Jak2-
mediated activation of Stat5. Activatory event is noted with a red or orange line
terminating in an arrowhead, and the inhibitory event is markedwith a blue line ending
with a bar. The solid line indicates genes affected by the direct loss of Elf5 and the
dashed line indicates genes for which the effects are likely to be indirect.
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2001). The phenotypic overlap between these knockout mouse
models implies that Elf5 transcription factor is directly or indirectly
associated with PrlR/Jak2/Stat5 signaling pathway. Interestingly,
unlike the Stat5a or PrlR-knockouts, but similar to Jak2 conditional
knockouts, multiple gestation cycles did not reverse this phenotype,
suggesting that other factors are not able to compensate for the loss of
Elf5 function. Interestingly, although the decrease of the overall Stat5a
levels induced by Elf5 loss was quite modest, we observed a drastic
decrease of p-Stat5 expression. One possibility is that Elf5 may
modulate the PrlR/Jak2-mediated phosphorylation of Stat5 through
regulating activities of genes involved in tyrosine phosphorylation of
Stat5 such as PrlR and Jak2. However, the expression of both PrlR and
Jak2 was not altered by Elf5 deletion. This result prompted us to
examine another possible modulation of phosphorylation of Stat5 by
Elf5-regulated inhibitors of the PrlR/Jak2 signaling since negative
regulators of the PrlR/Jak2/Stat5 signaling pathway such as SOCS
family members suppress the biological activities of the PrlR and Jak2
proteins without transcriptional downregulation (Pezet et al., 1999;
Tomic et al., 1999). Interestingly, multiple members of the SOCS family
were upregulated by the loss of Elf5. This suggests a dual mechanism
by which the loss of Elf5 leads to a signiﬁcant attenuation of the PrlR/
Jak2/Stat signaling pathway by both directly inhibiting Stat5 expres-
sion levels and concurrently upregulating negative mediators of Stat5
phosphorylation, thus leading to the loss of activated p-Stat5. This is
quite in agreement with our recent studies suggesting that Elf5 can
function as both transcriptional activator and repressor (Choi and
Sinha, 2006). However, it needs to be stressed that although Elf5 is
one of the critical regulator of the PRLR-mediated activation/
phosphorylation of Stat5, parallel pathways such as those mediated
by ERBB4 also operate during pregnancy induced functional differ-
entiation of mammary epithelium and may have overlapping roles
(Long et al., 2003).
It has been hypothesized that Elf5 is a downstream target of Stat5
(Oakes et al., 2006). Although, we do not rule out this possibility, ourdata seem to indicate that Elf5 is more likely to be upstreammediator
of the PrlR/Jak2/Stat pathway. As shown by ChIP experiments, we ﬁnd
Elf5 binding site in the proximal Stat5 promoter that is occupied by
Elf5. This correlates well with our observation that in Elf5-null
mammary glands and MECs, there is downregulation of Stat5
expression. The fact that Elf5 expression is not signiﬁcantly altered
in the Stat5 null animals (Dr. L. Hennighausen, personal communica-
tion) is further evidence in support of this argument. Finally, our
studies suggest that the effects of the loss of Elf5 are not limited to the
expression of critical members of PrlR/Jak2/Stat pathway but also
many other important critical players of lobuloalveolar development
(seeModel in Fig.10). At this stage, it is difﬁcult to discernwhether the
loss of expression of all of these critical mediators in the Elf5-null
mammary glands is a reﬂection as direct transcriptional targets of Elf5
or merely indicative of the block in differentiation phenotype. Our
preliminary data with Elf5-null MECs seems to indicate that Elf5 can
potentially directly regulate the expression of many of the target
genes important for lobuloalveologenesis, while for others, its effect
may be more indirect. Future studies to uncover the transcriptional
targets of Elf5 will be very useful in shedding light on the molecular
mechanisms by which this important transcription factor controls
several aspects of mammary gland development.
Acknowledgments
We are especially grateful to Dr. Lee Ann Garrett-Sinha (Depart-
ment of Biochemistry, StateUniversity of NewYork, Buffalo) for helpful
discussions and advice. We also thank KirstenW. Smalley for excellent
technical assistance in mouse husbandry and other members of our
laboratory for useful comments on this study. Thisworkwas supported
by National Institutes of Health Grant R01GM069417 (S.S.).
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.ydbio.2009.02.032.
References
Blackman, B., Russell, T., Nordeen, S.K., Medina, D., Neville, M.C., 2005. Claudin 7
expression and localization in the normal murine mammary gland and murine
mammary tumors. Breast Cancer Res. 7, R248–R255.
Brisken, C., Kaur, S., Chavarria, T.E., Binart, N., Sutherland, R.L., Weinberg, R.A., Kelly, P.A.,
Ormandy, C.J., 1999. Prolactin controls mammary gland development via direct and
indirect mechanisms. Dev. Biol. 210, 96–106.
Brisken, C., Rajaram, R.D., 2006. Alveolar and lactogenic differentiation. J. Mammary
Gland Biol. Neoplasia 11, 239–248.
Cao, Y., Bonizzi, G., Seagroves, T.N., Greten, F.R., Johnson, R., Schmidt, E.V., Karin, M.,
2001. IKKalpha provides an essential link between RANK signaling and cyclin D1
expression during mammary gland development. Cell 107, 763–775.
Choi, Y.S., Sinha, S., 2006. Determination of the consensus DNA-binding sequence and a
transcriptional activation domain for ESE-2. Biochem. J. 398, 497–507.
Choi, Y.S., Cheng, J., Segre, J., Sinha, S., 2008. Generation and analysis of Elf5-LacZmouse:
unique and dynamic expression of Elf5 (ESE-2) in the inner root sheath of cycling
hair follicles. Histochem. Cell Biol. 129, 85–94.
Derbinski, J., Pinto, S., Rosch, S., Hexel, K., Kyewski, B., 2008. Promiscuous gene
expression patterns in singlemedullary thymic epithelial cells argue for a stochastic
mechanism. Proc. Natl. Acad. Sci. U. S. A. 105, 657–662.
Desmaze, C., Brizard, F., Turc-Carel, C., Melot, T., Delattre, O., Thomas, G., Aurias, A., 1997.
Multiple chromosomal mechanisms generate an EWS/FLI1 or an EWS/ERG fusion
gene in Ewing tumors. Cancer Genet. Cytogenet. 97, 12–19.
Desprez, P.Y., Sumida, T., Coppe, J.P., 2003. Helix–loop–helix proteins in mammary gland
development and breast cancer. J. Mammary Gland Biol. Neoplasia 8, 225–239.
Dittmer, J., Nordheim, A., 1998. Ets transcription factors and human disease. Biochim.
Biophys. Acta 1377, F1–F11.
Donnison, M., Beaton, A., Davey, H.W., Broadhurst, R., L'Huillier, P., Pfeffer, P.L., 2005.
Loss of the extraembryonic ectoderm in Elf5 mutants leads to defects in embryonic
patterning. Development 132, 2299–2308.
Dunbar, M.E., Dann, P., Brown, C.W., Van Houton, J., Dreyer, B., Philbrick, W.P.,
Wysolmerski, J.J., 2001. Temporally regulated overexpression of parathyroid
hormone-related protein in the mammary gland reveals distinct fetal and pubertal
phenotypes. J. Endocrinol. 171, 403–416.
Faraldo, M.M., Deugnier, M.A., Lukashev, M., Thiery, J.P., Glukhova,M.A., 1998. Perturbation
of beta1-integrin function alters the development ofmurinemammary gland. EMBO J.
17, 2139–2147.
241Y.S. Choi et al. / Developmental Biology 329 (2009) 227–241Grimm, S.L., Seagroves, T.N., Kabotyanski, E.B., Hovey, R.C., Vonderhaar, B.K., Lydon, J.P.,
Miyoshi, K., Hennighausen, L., Ormandy, C.J., Lee, A.V., Stull, M.A., Wood, T.L., Rosen,
J.M., 2002. Disruption of steroid and prolactin receptor patterning in the mammary
gland correlates with a block in lobuloalveolar development. Mol. Endocrinol. 16,
2675–2691.
Harris, J., Stanford, P.M., Sutherland, K., Oakes, S.R., Naylor, M.J., Robertson, F.G., Blazek,
K.D., Kazlauskas, M., Hilton, H.N., Wittlin, S., Alexander, W.S., Lindeman, G.J.,
Visvader, J.E., Ormandy, C.J., 2006. Socs2 and elf5 mediate prolactin-induced
mammary gland development. Mol. Endocrinol. 20, 1177–1187.
Hennighausen, L., Robinson, G.W., 2005. Information networks in the mammary gland.
Nat. Rev., Mol. Cell Biol. 6, 715–725.
Hilkens, J., Ligtenberg, M.J., Vos, H.L., Litvinov, S.V., 1992. Cell membrane-associated
mucins and their adhesion-modulating property. Trends Biochem. Sci. 17, 359–363.
Lapinskas, E.J., Palmer, J., Ricardo, S., Hertzog, P.J., Hammacher, A., Pritchard, M.A., 2004.
A major site of expression of the ets transcription factor Elf5 is epithelia of exocrine
glands. Histochem. Cell Biol. 122, 521–526.
Long, W., Wagner, K.U., Lloyd, K.C., Binart, N., Shillingford, J.M., Hennighausen, L., Jones,
F.E., 2003. Impaired differentiation and lactational failure of Erbb4-deﬁcient
mammary glands identify ERBB4 as an obligate mediator of STAT5. Development
130, 5257–5268.
Ma, X.J., Salunga, R., Tuggle, J.T., Gaudet, J., Enright, E., McQuary, P., Payette, T., Pistone,
M., Stecker, K., Zhang, B.M., Zhou, Y.X., Varnholt, H., Smith, B., Gadd, M., Chatﬁeld, E.,
Kessler, J., Baer, T.M., Erlander, M.G., Sgroi, D.C., 2003. Gene expression proﬁles of
human breast cancer progression. Proc. Natl. Acad. Sci. U. S. A. 100, 5974–5979.
Metzger, D.E., Xu, Y., Shannon, J.M., 2007. Elf5 is an epithelium-speciﬁc, ﬁbroblast
growth factor-sensitive transcription factor in the embryonic lung. Dev. Dyn. 236,
1175–1192.
Mikaelian, I., Hovick, M., Silva, K.A., Burzenski, L.M., Shultz, L.D., Ackert-Bicknell, C.L.,
Cox, G.A., Sundberg, J.P., 2006. Expression of terminal differentiation proteins
deﬁnes stages of mouse mammary gland development. Vet. Pathol. 43, 36–49.
Miyoshi, K., Shillingford, J.M., Smith, G.H., Grimm, S.L., Wagner, K.U., Oka, T., Rosen, J.M.,
Robinson, G.W., Hennighausen, L., 2001. Signal transducer and activator of
transcription (Stat) 5 controls the proliferation and differentiation of mammary
alveolar epithelium. J. Cell Biol. 155, 531–542.
Miyoshi, K., Meyer, B., Gruss, P., Cui, Y., Renou, J.P., Morgan, F.V., Smith, G.H.,
Reichenstein, M., Shani, M., Hennighausen, L., Robinson, G.W., 2002. Mammary
epithelial cells are not able to undergo pregnancy-dependent differentiation in the
absence of the helix–loop–helix inhibitor Id2. Mol. Endocrinol. 16, 2892–2901.
Mori, S., Nishikawa, S.I., Yokota, Y., 2000. Lactation defect in mice lacking the helix–
loop–helix inhibitor Id2. EMBO J. 19, 5772–5781.
Naylor, M.J., Li, N., Cheung, J., Lowe, E.T., Lambert, E., Marlow, R., Wang, P., Schatzmann,
F., Wintermantel, T., Schuetz, G., Clarke, A.R., Mueller, U., Hynes, N.E., Streuli, C.H.,
2005. Ablation of beta1 integrin in mammary epithelium reveals a key role for
integrin in glandular morphogenesis and differentiation. J. Cell Biol. 171, 717–728.
Ng, R.K., Dean, W., Dawson, C., Lucifero, D., Madeja, Z., Reik, W., Hemberger, M., 2008.
Epigenetic restriction of embryonic cell lineage fate bymethylation of Elf5. Nat. Cell
Biol. 10, 1280–1290.
Oakes, S.R., Hilton, H.N., Ormandy, C.J., 2006. The alveolar switch: coordinating the
proliferative cues and cell fate decisions that drive the formation of lobuloalveoli
from ductal epithelium. Breast Cancer Res. 8, 207–216.
Oakes, S.R., Naylor, M.J., Asselin-Labat, M.L., Blazek, K.D., Gardiner-Garden, M., Hilton, H.
N., Kazlauskas, M., Pritchard, M.A., Chodosh, L.A., Pfeffer, P.L., Lindeman, G.J.,
Visvader, J.E., Ormandy, C.J., 2008. The Ets transcription factor Elf5 speciﬁes
mammary alveolar cell fate. Genes Dev. 22, 581–586.
Ormandy, C.J., Naylor, M., Harris, J., Robertson, F., Horseman, N.D., Lindeman, G.J.,
Visvader, J., Kelly, P.A., 2003. Investigation of the transcriptional changes underlying
functional defects in the mammary glands of prolactin receptor knockout mice.
Recent Prog. Horm. Res. 58, 297–323.Peter, M., Couturier, J., Pacquement, H., Michon, J., Thomas, G., Magdelenat, H., Delattre,
O., 1997. A newmember of the ETS family fused to EWS in Ewing tumors. Oncogene
14, 1159–1164.
Pezet, A., Favre, H., Kelly, P.A., Edery, M., 1999. Inhibition and restoration of prolactin
signal transduction by suppressors of cytokine signaling. J. Biol. Chem. 274,
24497–24502.
Rosen, J.M., Wyszomierski, S.L., Hadsell, D., 1999. Regulation of milk protein gene
expression. Annu. Rev. Nutr. 19, 407–436.
Rubins, N.E., Friedman, J.R., Le, P.P., Zhang, L., Brestelli, J., Kaestner, K.H., 2005.
Transcriptional networks in the liver: hepatocyte nuclear factor 6 function is largely
independent of Foxa2. Mol. Cell. Biol. 25, 7069–7077.
Sharrocks, A.D., 2001. The ETS-domain transcription factor family. Nat. Rev., Mol. Cell
Biol. 2, 827–837.
Sharrocks, A.D., Brown, A.L., Ling, Y., Yates, P.R., 1997. The ETS-domain transcription
factor family. Int. J. Biochem. Cell Biol. 29, 1371–1387.
Shillingford, J.M., Miyoshi, K., Flagella, M., Shull, G.E., Hennighausen, L., 2002. Mouse
mammary epithelial cells express the Na–K–Cl cotransporter, NKCC1: characteriza-
tion, localization, and involvement in ductal development andmorphogenesis. Mol.
Endocrinol. 16, 1309–1321.
Shillingford, J.M., Miyoshi, K., Robinson, G.W., Bierie, B., Cao, Y., Karin, M., Hennighausen,
L., 2003. Proteotyping of mammary tissue from transgenic and gene knockout mice
with immunohistochemical markers: a tool to deﬁne developmental lesions. J.
Histochem. Cytochem. 51, 555–565.
Starr, R., Willson, T.A., Viney, E.M., Murray, L.J., Rayner, J.R., Jenkins, B.J., Gonda, T.J.,
Alexander, W.S., Metcalf, D., Nicola, N.A., Hilton, D.J., 1997. A family of cytokine-
inducible inhibitors of signalling. Nature 387, 917–921.
Sum, E.Y., Shackleton, M., Hahm, K., Thomas, R.M., O'Reilly, L.A., Wagner, K.U., Lindeman,
G.J., Visvader, J.E., 2005. Loss of the LIM domain protein Lmo4 in the mammary
gland during pregnancy impedes lobuloalveolar development. Oncogene 24,
4820–4828.
Tepera, S.B., McCrea, P.D., Rosen, J.M., 2003. A beta-catenin survival signal is required for
normal lobular development in the mammary gland. J. Cell. Sci. 116, 1137–1149.
Thomas, R.S., Ng, A.N., Zhou, J., Tymms, M.J., Doppler, W., Kola, I., 2000. The Elf group of
Ets-related transcription factors. ELF3 and ELF5. Adv. Exp. Med. Biol. 480, 123–128.
Tomic, S., Chughtai, N., Ali, S., 1999. SOCS-1, -2, -3: selective targets and functions
downstream of the prolactin receptor. Mol. Cell. Endocrinol. 158, 45–54.
Tummala, R., Sinha, S., 2006. Differentiation-speciﬁc transcriptional regulation of the
ESE-2 gene by a novel keratinocyte-restricted factor. J. Cell. Biochem. 97, 766–781.
Wagner, K.U., Wall, R.J., St-Onge, L., Gruss, P., Wynshaw-Boris, A., Garrett, L., Li, M., Furth,
P.A., Hennighausen, L., 1997. Cre-mediated gene deletion in the mammary gland.
Nucleic Acids Res. 25, 4323–4330.
Wagner, K.U., McAllister, K., Ward, T., Davis, B., Wiseman, R., Hennighausen, L., 2001.
Spatial and temporal expression of the Cre gene under the control of the MMTV-
LTR in different lines of transgenic mice. Transgenic Res. 10, 545–553.
Woodward, W.A., Chen, M.S., Behbod, F., Rosen, J.M., 2005. On mammary stem cells.
J. Cell. Sci. 118, 3585–3594.
Yaniw, D., Hu, J., 2005. Epithelium-speciﬁc ets transcription factor 2 upregulates
cytokeratin 18 expression in pulmonary epithelial cells through an interactionwith
cytokeratin 18 intron 1. Cell Res. 15, 423–429.
Zhou, J., Ng, A.Y., Tymms, M.J., Jermiin, L.S., Seth, A.K., Thomas, R.S., Kola, I., 1998. A novel
transcription factor, ELF5, belongs to the ELF subfamily of ETS genes and maps to
human chromosome 11p13–15, a region subject to LOH and rearrangement in
human carcinoma cell lines. Oncogene 17, 2719–2732.
Zhou, J., Chehab, R., Tkalcevic, J., Naylor, M.J., Harris, J., Wilson, T.J., Tsao, S., Tellis, I.,
Zavarsek, S., Xu, D., Lapinskas, E.J., Visvader, J., Lindeman, G.J., Thomas, R., Ormandy,
C.J., Hertzog, P.J., Kola, I., Pritchard, M.A., 2005. Elf5 is essential for early
embryogenesis and mammary gland development during pregnancy and lactation.
EMBO J. 24, 635–644.
